Lv62
2360 积分 2022-03-08 加入
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients
1个月前
已完结
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
1个月前
已完结
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
1个月前
已完结
Biological therapy in Takayasu arteritis. Results from the REVAS registry
1个月前
已完结
The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for Takayasu Arteritis: A systematic review and meta-analysis
1个月前
已完结
Injurious Fall Risk Differences Among Older Adults With First-Line Depression Treatments
3个月前
已完结
Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study
6个月前
已完结
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
11个月前
已完结
Panfacial Approach to Rejuvenation Using Calcium Hydroxylapatite (CaHA): A Case Series Illustrating CaHA Versatility Through Dilution and a Multilayered Treatment Approach
11个月前
已关闭
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
11个月前
已完结
皖公网安备34019202002308
